| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_286c2fec2365cb7bdbc7abf4f230987e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2004-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baffef13eb7d8d998da381c2d3607fed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cad8605ab3e388e227fbf0ee3d63650 |
| publicationDate |
2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7138428-B2 |
| titleOfInvention |
Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same |
| abstract |
Disclosed herein are an acetone-extracted product obtained from gamboge resin and compounds further purified from said acetone-extracted product, including a new compound called formoxanthone A. The acetone-extracted product and the further purified compounds have been demonstrated to have activities in inhibiting the growth of tumor/cancer cells. Also disclosed are the processes for obtaining said further purified compounds, and the uses of the acetone-extracted product and the further purified compounds in the preparation of pharmaceutical composition for inhibiting the growth of tumor/cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498463-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3868365-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010040709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2684885-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2684882-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2684884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2684883-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011166216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2395007-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2395006-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8142818-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009043296-A1 |
| priorityDate |
2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |